Net sales increased 2.0%; Organic sales* increased 0.4%, including a 0.8% negative impact from lower private label pet sales having exited that non-strategic business.
GAAP EPS increased 1% to $0.91; Base Business EPS* was flat at $0.91
GAAP Gross profit margin decreased 170 basis points to 59.4%; Base Business Gross profit margin* decreased 190 basis points to 59.4%
Net cash provided by operations was $2,745 million for the first nine months of 2025
The Company’s leadership in toothpaste continued with its global market share at 41.2% year to date
The Company’s leadership in manual toothbrushes continued with its global market share at 32.4% year to date
The Company updated its organic sales growth guidance for the full year 2025 and maintained its earnings per share guidance
Colgate-Palmolive Company (NYSE: CL) today reported results for the third quarter 2025. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business third quarter results, “We are pleased to have delivered another quarter of net sales and organic sales growth, even in the face of slowing category growth in many markets and the negative impact from lower private label pet sales as we have exited that non-strategic business.
“As we transition to our new 2030 strategy and deploy our previously announced Strategic Growth and Productivity Program, we are well-positioned to reaccelerate growth despite uncertainty in global markets and lower worldwide category growth. The 2030 strategy is our blueprint for adapting to the challenges and capturing the opportunities of this more complex operating environment. Our organisation is aligned and motivated, with particular focus on accelerating our science-based innovation and omni-channel demand generation capabilities to drive category growth and market shares. The Strategic Growth and Productivity Program will help ensure we have the organisational structure and support we need to achieve our goals in the near term and deliver consistent compounded earnings per share growth over the long term.”
Full Year 2025 Guidance
Based on current spot rates and including the estimated impact of tariffs announced and finalised as of October 29, 2025:
The Company still expects net sales to be up low single digits, including a flat to low single-digit negative impact from foreign exchange.
The Company now expects organic sales growth to be 1% to 2%, roughly in line with year-to-date organic sales growth of 1.2%, versus the low end of 2% to 4% previously. This includes an approximately 70 basis point impact from our exit from private label pet sales.
On a GAAP basis, the Company now expects gross profit margin to be roughly in line with the year-to-date gross profit margin of 60.1% versus roughly flat previously, and still expects advertising to be roughly flat as a percentage of net sales and earnings per share to be up low single digits.
On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be roughly in line with the year-to-date gross profit margin of 60.1% versus roughly flat previously, and still expects advertising to be roughly flat as a percentage of net sales and earnings per share to be up low single digits.